Our passion for progress leads us to invest more than 15 percent of our sales revenue in research and development activities.  Solvay Pharmaceuticals’ global research and development initiative employs more than 1,000 professionals worldwide who jointly engage in the discovery and development of new treatments.  Key locations anchoring this global network include Hannover, Germany; Marietta, Ga.; Tokyo, Japan; and Weesp, The Netherlands.  Solvay Pharmaceuticals has a history of innovative drug development, including first-to-market and category leading products among its core therapeutic areas.  Research scientists join Solvay Pharmaceuticals because of its rich history and track record of bold innovations.  While some scientists spend their careers in search of the next blockbuster drug therapy, our innovators are given the time and dedicated resources it takes to win smaller scale victories focused on our niche therapeutic areas of cardiology, gastroenterology, mental health, women’s health and specialized markets.  Our R&D efforts target often-neglected and under-treated patient groups. This world-class research network is the foundation of our efforts to help people with true medical needs.  Our pipeline strength across core therapeutic areas reflects the success of this globalized research function that connects colleagues from every corner of the world.